Last updated: July 10, 2026

Application No. 19/383,237

Untitled Application

Unknown

Filed

Priority

May 12, 2022 — provisional 63/364,609 +1 more

Examiner

MCLEOD, AFRICA MHAIRIE

Art Unit

Tech Center

Dicerna Pharmaceuticals, Inc.

Assignee

Dicerna Pharmaceuticals Inc.

OA Round

1 (Non-Final)

This examiner grants 49% of cases after interview

— +71.5% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 43 resolved cases, 2023–2026

Examiner Intelligence

MCLEOD, AFRICA MHAIRIE View full profile →

Grants 49% of resolved cases

Career Allowance Rate

21 granted / 43 resolved

-11.2% vs TC avg

Strong +72% interview lift

Without

With

+71.5%

Interview Lift

resolved cases with interview

Typical timeline

3y 9m

Avg Prosecution

34 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

37.7%

-2.3% vs TC avg

§102

3.0%

-37.0% vs TC avg

§112

9.6%

-30.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 43 resolved cases

Prosecution Timeline

Apr 21, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/905,934

Patent 12649917

COMPOSITIONS, METHODS, AND SYSTEMS FOR GENOME EDITING TECHNOLOGY

3y 9m to grant Granted Jun 09, 2026

17/614,534

Patent 12624401

SINGLE INPUT MULTIPLEX DECISION SYSTEMS AND METHODS OF USING THE SAME

4y 5m to grant Granted May 12, 2026

17/372,676

Patent 12522822

APOLIPOPROTEIN C3 (APOC3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

4y 6m to grant Granted Jan 13, 2026

17/602,244

Patent 12514868

Multiplex shRNA for Use in Vectors

4y 3m to grant Granted Jan 06, 2026

17/719,123

Patent 12516353

RECOMBINANT HERPESVIRUS OF TURKEYS (HVT) AND PREPARATION METHOD AND USE THEREOF

3y 9m to grant Granted Jan 06, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

49%

Grant Probability

99%

With Interview (+71.5%)

3y 9m

Median Time to Grant

Low

PTA Risk

Based on 43 resolved cases by this examiner. Grant probability derived from career allowance rate.